Table 5. Comparisons of fetuin-A levels according to various clinical/laboratory parameters.

Significant p values (less than 0.05) are highlighted in bold.^* Apocrine, papillary, mucinous, metaplastic, neuroendocrine, tubular. ^** Invasive ductal carcinoma, invasive lobular carcinoma, mixed type.

Variables	Fetuin Median (Range)	n	P
Ki-67
≤ 30	0.345 (0.235–0.522)	43<br>71	0.09
> 30	0.389 (0.224–0.743)	71
ER
Negative	0.398 (0.264–0.692)	25	0.38
Positive	0.375 (0.224–0.743)	92
PR
Negative	0.399 (0.247–0.692)	30	0.38
Positive	0.373 (0.224–0.743)	87
HER2
Negative	0.362 (0.224–0.743)	90	0.71
Positive	0.369 (0.249–0.692)	24
Classification
Luminal	0.358 (0.224–0.743)	92	0.39
Others	0.392 (0.264–0.692)<br>9225	25
Classification
Triple positive	0.345 (0.249–0.497)	13	0.40
Others	0.368 (0.224–0.743)	100
Classification
Triple negative	0.336 (0.267–0.591)	11	0.63
Others	0.362 (0.224–0.743)	106
Classification
HER2 enriched	0.369 (0.249–0.692)	24	0.71
Others	0.362 (0.224–0.743)	90
Histological subgroups
Favorable groups*	0.355 (0.242–0.526)<br>0.355 (0.242-0.526)	24	0.51
Unfavorable groups**	0.361 (0.224–0.743)	93
Stage
Early stage	0.360 (0.224–0.650)	60	0.55
Local advanced stage	0.370 (0.235–0.743)	54